ZYME (ZYME) Institutional Ownership
None of the superinvestors we track currently report ZYME in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in ZYME, this page will show institutional position trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q4 2025 | 1 | $5,815,691 | 220,877 |
| Q3 2025 | 1 | $7,373,436 | 431,700 |
| Q2 2025 | 1 | $6,692,915 | 533,300 |
| Q1 2025 | 1 | $5,366,646 | 450,600 |
| Q4 2024 | 1 | $4,182,648 | 285,700 |
| Q3 2024 | 1 | $2,316,730 | 184,600 |
| Q2 2024 | 1 | $2,015,006 | 236,781 |
| Q1 2024 | 1 | $1,216 | 115,600 |
| Q4 2023 | 1 | $153 | 14,700 |
| Q3 2023 | 1 | $101 | 15,858 |
| Q2 2023 | 1 | $2,265 | 262,137 |
| Q1 2023 | 1 | $754 | 83,400 |
Related ZYME Institutional Insights:
- ZYME Institutional Ownership & Insiders Activity
- ZYME Institutional Ownership & 13F Activity
- ZYME Top Institutional Shareholders
- ZYME Institutional Buying Activity
- ZYME Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- ZYME Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings